Measuring Quality of Life Following Robot-Assisted Radical Prostatectomy

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.21590
   PubMed Web of Science ®Google Scholar
• Mohler JL, Antonarakis ES, Armstrong AJ, et al. Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17(5):479–505. doi:10.6004/jnccn.2019.0023
   PubMed Web of Science ®Google Scholar
• Sanda MG, Cadeddu JA, Kirkby E, et al. Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. part I: risk stratification, shared decision making, and care options. J Urol. 2018;199(3):683–690. doi:10.1016/j.juro.2017.11.095
   PubMed Web of Science ®Google Scholar
• Hamdy FC, Donovan JL, Lane JA, et al. 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med. 2016;375(15):1415–1424. doi:10.1056/NEJMoa1606220
   PubMed Web of Science ®Google Scholar
• Oberlin DT, Flum AS, Lai JD, et al. The effect of minimally invasive prostatectomy on practice patterns of American urologists. Urol Oncol. 2016;34(6):255–e1. doi:10.1016/j.urolonc.2016.01.008
   Web of Science ®Google Scholar
• Lowrance WT, Eastham JA, Savage C, et al. Contemporary open and robotic radical prostatectomy practice patterns among urologists in the United States. J Urol. 2012;187(6):2087–2093. doi:10.1016/j.juro.2012.01.061
   PubMed Web of Science ®Google Scholar
• Binder J, Kramer W. Robotically-assisted laparoscopic radical prostatectomy. BJU International. 2001;87(4):408–410. doi:10.1046/j.1464-410x.2001.00115.x
   PubMed Web of Science ®Google Scholar
• Crew B. Worth the cost? A closer look at the da Vinci robot’s impact on prostate cancer surgery. Nature Index Cancer. 2020;580(7804):S5–S7.
   Google Scholar
• Leow JJ, Chang SL, Meyer CP, et al. Robot-assisted versus open radical prostatectomy: a contemporary analysis of an all-payer discharge database. Eur Urol. 2016;70(5):837–845. doi:10.1016/j.eururo.2016.01.044
   Web of Science ®Google Scholar
• International Health Conference. Constitution of the World Health Organization. Bull World Health Organ. 1946;80:983.
   Google Scholar
• Guidance for industry use in medical product development to support labeling claims guidance for industry. Food and Drug Administration; 2009.
   Google Scholar
• Milne A, Johnson JA, Tennant M, et al. Measuring health-related quality of life for patients with diabetic retinopathy. Agency for Healthcare Research and Quality (US); 2012.
   Google Scholar
• Basch E. New frontiers in patient-reported outcomes: adverse event reporting, comparative effectiveness, and quality assessment. Annu Rev Med. 2014;65:307–317. doi:10.1146/annurev-med-010713-141500
   PubMed Web of Science ®Google Scholar
• Selby JV, Beal AC, Frank L. The Patient-Centered Outcomes Research Institute (PCORI) national priorities for research and initial research agenda. JAMA. 2012;307(15):1583–1584. doi:10.1001/jama.2012.500
   PubMed Web of Science ®Google Scholar
• Cella D, Yount S, Rothrock N, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care. 2007;45(5 Suppl 1):S3–S11. doi:10.1097/01.mlr.0000258615.42478.55
   PubMed Web of Science ®Google Scholar
• National Institutes of Health - Patient-reported outcomes measurement information system (PROMIS. Available from: https://www.healthmeasures.net/explore-measurement-systems/promis. Accessed March 21 2021.
   Google Scholar
• Northwestern University. Health measures. Available from: https://www.healthmeasures.net/index.php. Accessed March 21 2021.
   Google Scholar
• Chen RC, Chang P, Vetter RJ, et al. Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials. J Natl Cancer Inst. 2014;106:7. doi:10.1093/jnci/dju132
   Google Scholar
• Reeve BB, Mitchell SA, Dueck AC, et al. Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst. 2014;106(7):dju129–dju129. doi:10.1093/jnci/dju129
   PubMed Web of Science ®Google Scholar
• Patient-Centered Outcomes Research Institute. Our Vision and Mission. Available from: https://www.pcori.org/about-us/our-vision-mission. Accessed March 21 2021.
   Google Scholar
• Talwar R, Dobbs RW, Stambakio H, et al. A longitudinal cohort study of pain intensity and interference after ureteroscopy for nephrolithiasis without postoperative opioids. Urology. 2021;147:81–86. doi:10.1016/j.urology.2020.09.042
   Web of Science ®Google Scholar
• Narang GL, Pannell SC, Laviana AA, et al. Patient-reported outcome measures in urology. Curr Opin Urol. 2017;27(4):366–374. doi:10.1097/MOU.0000000000000412
   Web of Science ®Google Scholar
• Miller DC, Sanda MG, Dunn RL, et al. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol. 2005;23(12):2772–2780. doi:10.1200/JCO.2005.07.116
   PubMed Web of Science ®Google Scholar
• Litwin MS, Hays RD, Fink A, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995;273(2):129–135. doi:10.1001/jama.1995.03520260051032
   PubMed Web of Science ®Google Scholar
• Wei JT, Dunn RL, Sandler HM, et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol. 2002;20(2):557–566. doi:10.1200/JCO.2002.20.2.557
   PubMed Web of Science ®Google Scholar
• Madalinska JB, Essink-Bot M-L, de Koning HJ, et al. Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. J Clin Oncol. 2001;19(6):1619–1628. doi:10.1200/JCO.2001.19.6.1619
   PubMed Web of Science ®Google Scholar
• Talcott JA, Rieker P, Clark JA, et al. Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. J Clin Oncol. 1998;16(1):275–283. doi:10.1200/JCO.1998.16.1.275
   PubMed Web of Science ®Google Scholar
• Talcott JA, Rieker P, Propert KJ, et al. Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst. 1997;89(15):1117–1123. doi:10.1093/jnci/89.15.1117
   PubMed Web of Science ®Google Scholar
• Litwin MS, McGuigan KA. Accuracy of recall in health-related quality-of-life assessment among men treated for prostate cancer. J Clin Oncol. 1999;17(9):2882–2888. doi:10.1200/JCO.1999.17.9.2882
   PubMed Web of Science ®Google Scholar
• Cappelleri JC, Rosen RC. The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res. 2005;17(4):307–319. doi:10.1038/sj.ijir.3901327
   PubMed Web of Science ®Google Scholar
• Weinfurt KP, Lin L, Bruner DW, et al. Development and initial validation of the PROMIS® sexual function and satisfaction measures version 2.0. J Sex Med. 2015;12(9):1961–1974. doi:10.1111/jsm.12966
   PubMed Web of Science ®Google Scholar
• Rosen RC, Riley A, Wagner G, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822–830. doi:10.1016/S0090-4295(97)00238-0
   PubMed Web of Science ®Google Scholar
• Esper P, Mo F, Chodak G, et al. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology. 1997;50(6):920–928. doi:10.1016/S0090-4295(97)00459-7
   PubMed Web of Science ®Google Scholar
• Wei JT, Dunn RL, Litwin MS, et al. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56(6):899–905. doi:10.1016/S0090-4295(00)00858-X
   PubMed Web of Science ®Google Scholar
• Borghede G, Sullivan M. Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30. Qual Life Res. 1996;5(2):212–222. doi:10.1007/BF00434743
   Web of Science ®Google Scholar
• Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483. doi:10.1097/00005650-199206000-00002
   PubMed Web of Science ®Google Scholar
• Litwin MS, Hays RD, Fink A, et al. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care. 1998;36(7):1002–1012. doi:10.1097/00005650-199807000-00007
   Web of Science ®Google Scholar
• Singh K, Tin AL, Dunn RL, et al. Development and validation of crosswalks for patient-reported sexual and urinary outcomes between commonly used instruments. Eur Urol. 2019;75(5):723–730. doi:10.1016/j.eururo.2018.12.002
   Web of Science ®Google Scholar
• Dobbs RW, Magnan BP, Abhyankar N, et al. Cost effectiveness and robot-assisted urologic surgery: does it make dollars and sense? Minerva Urol Nefrol. 2017;69(4):313–323. doi:10.23736/S0393-2249.16.02866-6
   Web of Science ®Google Scholar
• Novara G, Ficarra V, Rosen RC, et al. Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomy. Eur Urol. 2012;62(3):431–452. doi:10.1016/j.eururo.2012.05.044
   PubMed Web of Science ®Google Scholar
• Yaxley JW, Coughlin GD, Chambers SK, et al. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled Phase 3 study. Lancet. 2016;388(10049):1057–1066. doi:10.1016/S0140-6736(16)30592-X
   PubMed Web of Science ®Google Scholar
• Akand M, Celik O, Avci E, et al. Open, laparoscopic and robot-assisted laparoscopic radical prostatectomy: comparative analysis of operative and pathologic outcomes for three techniques with a single surgeon’s experience. Eur Rev Med Pharmacol Sci. 2015;19(4):525–531.
   Web of Science ®Google Scholar
• Alemozaffar M, Sanda M, Yecies D, et al. Benchmarks for operative outcomes of robotic and open radical prostatectomy: results from the health professionals follow-up study. Eur Urol. 2015;67(3):432–438. doi:10.1016/j.eururo.2014.01.039
   PubMed Web of Science ®Google Scholar
• Murphy D, Challacombe B, Khan MS, et al. Robotic technology in urology. Postgrad Med J. 2006;82(973):743–747. doi:10.1136/pgmj.2006.048140
   Web of Science ®Google Scholar
• O’Neil B, Koyama T, Alvarez J, et al. The comparative harms of open and robotic prostatectomy in population based samples. J Urol. 2016;195(2):321–329. doi:10.1016/j.juro.2015.08.092
   Web of Science ®Google Scholar
• Coughlin GD, Yaxley JW, Chambers SK, et al. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study. Lancet Oncol. 2018;19(8):1051–1060. doi:10.1016/S1470-2045(18)30357-7
   PubMed Web of Science ®Google Scholar
• De Carlo F, Celestino F, Verri C, et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: surgical, oncological, and functional outcomes: a systematic review. Urol Int. 2014;93(4):373–383. doi:10.1159/000366008
   PubMed Web of Science ®Google Scholar
• Ficarra V, Novara G, Rosen RC, et al. Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol. 2012;62(3):405–417. doi:10.1016/j.eururo.2012.05.045
   PubMed Web of Science ®Google Scholar
• Breyer BN, Davis CB, Cowan JE, et al. Incidence of bladder neck contracture after robot-assisted laparoscopic and open radical prostatectomy. BJU International. 2010;106(11):1734–1738. doi:10.1111/j.1464-410X.2010.09333.x
   Web of Science ®Google Scholar
• Msezane LP, Reynolds WS, Gofrit ON, et al. Bladder neck contracture after robot-assisted laparoscopic radical prostatectomy: evaluation of incidence and risk factors and impact on urinary function. J Endourol. 2008;22(1):97–104. doi:10.1089/end.2006.0460
   Web of Science ®Google Scholar
• Sharma V, Wymer KM, Borah BJ, et al. Cost-effectiveness of active surveillance, radical prostatectomy and external beam radiotherapy for localized prostate cancer: an analysis of the protect trial. J Urol. 2019;202(5):964–972. doi:10.1097/JU.0000000000000345
   Web of Science ®Google Scholar
• Tomaszewski JJ, Matchett JC, Davies BJ, et al. Comparative hospital cost-analysis of open and robotic-assisted radical prostatectomy. Urology. 2012;80(1):126–129. doi:10.1016/j.urology.2012.03.020
   Web of Science ®Google Scholar
• Bolenz C, Gupta A, Hotze T, et al. Cost comparison of robotic, laparoscopic, and open radical prostatectomy for prostate cancer. Eur Urol. 2010;57(3):453–458. doi:10.1016/j.eururo.2009.11.008
   Web of Science ®Google Scholar
• Mukherjee K, Kamal KM. Variation in prostate surgery costs and outcomes in the USA: robot-assisted versus open radical prostatectomy. J Comp Eff Res. 2019;8(3):143–155. doi:10.2217/cer-2018-0109
   Web of Science ®Google Scholar
• Forsmark A, Gehrman J, Angenete E, et al. Health economic analysis of open and robot-assisted laparoscopic surgery for prostate cancer within the prospective multicentre LAPPRO trial. Eur Urol. 2018;74(6):816–824. doi:10.1016/j.eururo.2018.07.038
   PubMed Web of Science ®Google Scholar
• Close A, Robertson C, Rushton S, et al. Comparative cost-effectiveness of robot-assisted and standard laparoscopic prostatectomy as alternatives to open radical prostatectomy for treatment of men with localised prostate cancer: a health technology assessment from the perspective of the UK National Health Service. Eur Urol. 2013;64(3):361–369. doi:10.1016/j.eururo.2013.02.040
   Web of Science ®Google Scholar
• Bijlani A, Hebert AE, Davitian M, et al. A multidimensional analysis of prostate surgery costs in the United States: robotic-assisted versus retropubic radical prostatectomy. Value Health. 2016;19(4):391–403. doi:10.1016/j.jval.2015.12.019
   Web of Science ®Google Scholar
• Moran PS, O’Neill M, Teljeur C, et al. Robot-assisted radical prostatectomy compared with open and laparoscopic approaches: a systematic review and meta-analysis. Int J Urol. 2013;20(3):312–321. doi:10.1111/iju.12070
   Web of Science ®Google Scholar
• Ficarra V, Novara G, Ahlering TE, et al. Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. Eur Urol. 2012;62(3):418–430. doi:10.1016/j.eururo.2012.05.046
   PubMed Web of Science ®Google Scholar
• Kang DC, Hardee MJ, Fesperman SF, et al. Low quality of evidence for robot-assisted laparoscopic prostatectomy: results of a systematic review of the published literature. Eur Urol. 2010;57(6):930–937. doi:10.1016/j.eururo.2010.01.034
   Web of Science ®Google Scholar
• Barocas DA, Alvarez J, Resnick MJ, et al. Association between radiation therapy, surgery, or observation for localized prostate cancer and patient-reported outcomes after 3 years. JAMA. 2017;317(11):1126–1140. doi:10.1001/jama.2017.1704
   PubMed Web of Science ®Google Scholar
• Punnen S, Cowan JE, Chan JM, et al. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry. Eur Urol. 2015;68(4):600–608. doi:10.1016/j.eururo.2014.08.074
   PubMed Web of Science ®Google Scholar
• Chen RC, Basak R, Meyer AM, et al. Association between choice of radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance and patient-reported quality of life among men with localized prostate cancer. JAMA. 2017;317(11):1141–1150. doi:10.1001/jama.2017.1652
   PubMed Web of Science ®Google Scholar
• Wu AK, Cooperberg MR, Sadetsky N, et al. Health related quality of life in patients treated with multimodal therapy for prostate cancer. J Urol. 2008;180(6):2415–2422. doi:10.1016/j.juro.2008.08.015
   Web of Science ®Google Scholar
• van Stam MA, Aaronson NK, Bosch JLHR, et al. Patient-reported outcomes following treatment of localised prostate cancer and their association with regret about treatment choices. Eur Urol Oncol. 2020;3(1):21–31. doi:10.1016/j.euo.2018.12.004
   Web of Science ®Google Scholar
• Hoffman RM, Lo M, Clark JA, et al. Treatment decision regret among long-term survivors of localized prostate cancer: results from the prostate cancer outcomes study. J Clin Oncol. 2017;35(20):2306–2314. doi:10.1200/JCO.2016.70.6317
   PubMed Web of Science ®Google Scholar
• Baunacke M, Schmidt ML, Groeben C, et al. Decision regret after radical prostatectomy does not depend on surgical approach: 6-year followup of a large german cohort undergoing routine care. J Urol. 2020;203(3):554–561. doi:10.1097/JU.0000000000000541
   Web of Science ®Google Scholar
• Lindsay J, Uribe S, Moschonas D, et al. Patient satisfaction and regret after robot-assisted radical prostatectomy: a decision regret analysis. Urology. 2021;149:122–128. doi:10.1016/j.urology.2020.12.015
   Web of Science ®Google Scholar
• Lam WWT, Tse MA, Ng CNL, et al. Psychometric assessment of the Chinese version of the abbreviated expanded prostate cancer index composite (EPIC-26) and the clinical practice version (EPIC-CP) in Chinese men with prostate cancer. J Pain Symptom Manage. 2017;53(6):1085–1090. doi:10.1016/j.jpainsymman.2017.02.010
   Web of Science ®Google Scholar
• Marzorati C, Monzani D, Mazzocco K, et al. Validation of the Italian version of the abbreviated expanded prostate Cancer index composite (EPIC-26) in men with prostate Cancer. Health Qual Life Outcomes. 2019;17(1):147. doi:10.1186/s12955-019-1214-x
   Web of Science ®Google Scholar
• Axcrona K, Nilsson R, Brennhovd B, et al. Psychometric properties of the expanded prostate cancer index composite - 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations. BMC Urol. 2017;17(1):111. doi:10.1186/s12894-017-0302-7
   Web of Science ®Google Scholar
• Takegami M, Suzukamo Y, Sanda MG, et al. [The Japanese translation and cultural adaptation of Expanded Prostate Cancer Index Composite (EPIC)]. Nihon Hinyokika Gakkai Zasshi. 2005;96(7):657–669. [Japanese]. doi:10.5980/jpnjurol1989.96.657
   PubMedGoogle Scholar
• Alves E, Medina R, Andreoni C. Validation of the Brazilian version of the Expanded Prostate Cancer Index Composite (EPIC) for patients submitted to radical prostatectomy. Int Braz J Urol. 2013;39(3):344–352. doi:10.1590/S1677-5538.IBJU.2013.03.07
   Web of Science ®Google Scholar
• Anota A, Mariet AS, Maingon P, et al. Cross-cultural adaptation and validation of the French version of the Expanded Prostate cancer Index Composite questionnaire for health-related quality of life in prostate cancer patients. Health Qual Life Outcomes. 2016;14(1):168. doi:10.1186/s12955-016-0571-y
   Web of Science ®Google Scholar
• Umbehr MH, Bachmann LM, Poyet C, et al. The German version of the Expanded Prostate Cancer Index Composite (EPIC): translation, validation and minimal important difference estimation. Health Qual Life Outcomes. 2018;16(1):36. doi:10.1186/s12955-018-0859-1
   PubMed Web of Science ®Google Scholar
• Izard JP. The emerging role of patient-reported outcomes in urology. Can Urol Assoc J. 2017;11(12):411. doi:10.5489/cuaj.5007
   Web of Science ®Google Scholar
• Lee DJ, Avulova S, Conwill R, et al. Patient engagement in the design and execution of urologic oncology research. Urol Oncol. 2017;35(9):552–558. doi:10.1016/j.urolonc.2017.07.002
   Web of Science ®Google Scholar
• Tran C, Dicker A, Leiby B, et al. Utilizing digital health to collect electronic patient-reported outcomes in prostate cancer: single-arm pilot trial. J Med Internet Res. 2020;22(3):e12689. doi:10.2196/12689
   Web of Science ®Google Scholar
• Dobbs RW, Halgrimson WR, Madueke I, et al. Single-port robot-assisted laparoscopic radical prostatectomy: initial experience and technique with the da Vinci® SP platform. BJU Int. 2019;124(6):1022–1027. doi:10.1111/bju.14864
   Web of Science ®Google Scholar
• Lai A, Dobbs RW, Talamini S, et al. Single port robotic radical prostatectomy: a systematic review. Transl Androl Urol. 2020;9(2):898–905. doi:10.21037/tau.2019.11.05
   Web of Science ®Google Scholar
• Dobbs RW, Halgrimson WR, Talamini S, et al. Single-port robotic surgery: the next generation of minimally invasive urology. World J Urol. 2020;38(4):897–905. doi:10.1007/s00345-019-02898-1
   PubMed Web of Science ®Google Scholar
• Samalavicius NE, Janusonis V, Siaulys R, et al. Robotic surgery using Senhance((R)) robotic platform: single center experience with first 100 cases. J Robot Surg. 2020;14(2):371–376. doi:10.1007/s11701-019-01000-6
   PubMed Web of Science ®Google Scholar